Ljubljana stock indices edge up in lower turnover
Bosnia's Federation retail sales up real 8.8% y/y in Oct
Most Sofia bourse indices end higher, Eurohold paces gainers
Podravka, Adris boost Croatia’s share indices in lower turnover
Romanian stock indices turn green, MedLife shines
Dec 29, 2017 12:03 EEST
December 29 (SeeNews) - Macedonian drug maker Alkaloid [MSE:ALK] said on Friday that it expects a 7% increase of its consolidated net profit to 13.5 million euro ($16.2 million) in 2018.
The company also expects 7% increase in its sales revenues, Alkaloid said in its 2018 business plan filed on the Macedonian Stock Exchange.
The company said it expects to generate about 63% of its sales abroad and 37%on the domestic market.
In 2016, the company's net profit amounted to 11.9 million euro. For 2017, Alkaloid sees its profit reaching 12.6 million euro.
Alkaloid has three subsidiaries in Macedonia, as well as 14 subsidiaries and four representative offices abroad. Alkaloid also operates a laboratory in Slovenia for the purposes of batch testing and release in the European Union.
($ = 0.8343 euro)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options